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Copper is a cofactor of the formylglycine generating enzyme 
 Matthias Knop,[a] Thanh Quy Dang[a], Gunnar Jeschke[b] and Florian P. Seebeck[a]* 
Abstract: The formylglycine generating enzyme (FGE) is an O2 
utilizing oxidase that converts specific cysteine residues of client 
proteins to formylglycine. In this report we show that Cu(I) is an 
integral cofactor of this enzyme and binds with high affinity (KD = 
of 10-17 M) to a pair of active site cysteines. These findings 
establish FGE as a novel type of copper enzyme.   
Formylglycine generating enzymes (FGE) catalyze O2 
dependent conversion of specific cysteine residues on client 
proteins to formylglycine (fGly) (Scheme 1). This 
posttranslational modification is essential for the catalytic 
activity of phosphatases and sulfatases.[1] FGE activity in 
human cells lead to sulfatase deficiencies.[2] In addition, FGE 
has emerged as a versatile tool for protein engineering, 
because it can introduce unique aldehyde functions into 
recombinant proteins. [1a, 3] Initial biochemical and structural 
characterization of this enzyme raised an interesting 
mechanistic question: How does this enzyme activate O2? 
None of the published crystal structures of this catalyst 
revealed any known redox cofactor.[4] The only redox active 
features in the active site are two conserved cysteine 
residues which by themselves can hardly activate O2.[5],[6] One 
electron transfers between thiols and O2 are prohibited by 
mismatched redox potentials, and ionic mechanisms are spin 
forbidden. 
Recently we and others found that copper salts increase the 
in vitro activity of FGE by up to 20-fold.[7] Although copper is a 
plausible agent in O2 activation,[8] the interaction between 
FGE and transition metals remained mysterious.  
The general absence of copper in published crystal structures 
suggested that a potential FGE:copper complex may not be 
very stable.[4] On the other hand, Cu(I) dependent FGE 
activity is not affected by millimolar concentrations of 
EDTA,[7b] which is a strong ligand for Cu(II) (pKD = 18.8) or 
DTT, which is a strong ligand for Cu(I) (pKD = 15.3).[9] Hence, 
FGE is either an even stronger copper ligand, or does not 
require direct metallation. In this later scenario copper may 
serve as an artificial source of electrons or activated oxygen 
species in the in vitro assay.[10] 
In this report we address this puzzle. We show that FGE from 
Thermomonospora curvata (FGEcurvata) binds Cu(I) with an 
affinity reminiscent of known high-affinity copper proteins.[9] 
We found that Cu(I) binds to both active site cysteines and  
Scheme 1. FGE catalyzes O2-dependent conversion of cysteine residues 
to formylglycine (fGly), H2S and water. To complete the four electron 
reduction of O2, the enzyme requires an auxiliary reducing agent such as 
DTT. 
remains bound throughout multiple catalytic cycles. We have 
previously shown that the active site cysteines of FGEcurvata 
readily form a disulfide bond under standard aerobic 
conditions.[7b] To allow unambiguous determination of the 
redox state of these two residues, we constructed an FGE 
variant in which all cysteines outside the active site are 
mutated to either serine or alanine (FGE4C).[7b] This variant 
proved seven-fold more active than wild type,[7b] and therefore 
was used for most of our subsequent experiments. Using 
FGE4C as a model we could show that the two active site 
cysteines form a disulfide bond when the purified enzyme is 
stored in the absence of a reducing agent. [7b]    
To estimate Cu(I) affinities of FGEcurvata and FGE4C we used a 
published titration assay.[9] A solution containing the 1:2 
complex between Cu(I) and bathocuproine disulfonate 
(Cu(I):(BCS)2) was titrated with FGE4C (Figure S1). Transfer 
of Cu(I) from the BCS complex to FGE was monitored by 
measuring the decreasing absorption of the Cu(I):(BCS)2 
complex at 483 nm. This qualitative experiment revealed that 
oxidized FGE4C has no greater affinity for Cu(I) than the 
control protein bovine serum albumin (BSA). By contrast, 
FGE4C purified in reduced form showed significant Cu(I) 
affinity (Figure S1). Because the oxidized and reduced form 
of FGE4C only differ by the redox state of the two active site 
cysteines, we concluded that these thiols must be essential 
for Cu(I) binding.  
For a more quantitative estimation of KD,Cu(I) we recorded the 
absorption at 483 nm as a function of FGE4C or FGEcurvata 
concentration and fitted the resulting curves to an equation 
describing the equilibrium between the Cu(I):(BCS)2 complex 
and the FGE:Cu(I) complex (see supporting information).[9] All 
titration buffers contained 2 mM cysteamine to keep the 
enzymes in reduced form. Because cysteamine is a 
comparably weak Cu(I) binder (KD = 10-14.1 M) (Table 1), its 
presence should not affect the apparent Cu (I) affinity of FGE. 
As a test of this assumption we determined the apparent 
Cu(I) affinity of DTT in the absence (KD = 10-15.1 M) and in the 
presence (KD,cysteamine = 10-15.6 M) of cysteamine. Both values 
are in fair agreement with the published value (KD,lit = 10-15.3 
M).[9] With this assay we determined an apparent dissociation 
constant (KD, Table 1) of the Cu(I) complexes with FGE4C or  
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Table 1. Kinetic parameters and Cu(I) affinities of FGE 
variants and auxiliary thiols.a  
 kcat  
[min-1] 
KM  
[M] 
kcat/ KM  
[min-1M-1] 
pKD,Cu (I) 
FGEcurvata 1.6 ± 0.1 580 ± 40 2900 ± 50 17.1 i 
FGE4C 4.2 ± 0.5 230 ± 40 20 000 ± 4000 17.1 i 
FGES266A 0.006 520 ± 240 49 ± 8 17.7 i 
FGES290K n.a. n.a. 6.6 ± 0.2 16.7 i 
FGEC269S n.a. n.a. ≤ 1 n.a. 
FGEC274S n.a. n.a. ≤ 1 n.a. 
Cysteamine    14.1ii  
DTT    15.1ii,15.6 i 
DTBA    15.8ii 
 
a) Michaelis Menten parameters for FGE catalysed oxidation of a Cys 
containing substrate peptide to the fGly-containing product were 
determined as described in the supporting information. n.a.) low specific 
activities prevented accurate determination of these parameters. Apparent 
dissociation constants (KD) of Cu (I) complexes with FGE variants or low 
molecular weight thiols were determined using a published titration 
assay.[9] i) these values were determined in the presence of 2 mM 
cysteamine. ii) in the absence of additional thiols. 
 
FGEcurvata. Since both proteins bind Cu(I) with similar strength 
we concluded that none of the Cys residues outside the 
active site contributes to copper binding. Similar complex 
stabilities have been reported for copper chaperones from 
humans (Atox1, KD = 10-17 M)[9], Saccharomyces cerevisiae 
(Atx1, KD = 10-17 M)[9] or Bacillus subtilis (CopZ, KD = 10-17 
M),[11] suggesting that FGE should be well equipped to 
procure copper in a cellular context.[12] 
On the other hand, it remains puzzling that FGE is fully active 
in a millimolar DTT solution. The apparent Cu(I) affinity of 
DTT is 102-fold lower than that of FGE.  A 103-fold excess of 
DTT should therefore destabilize the FGE:Cu(I) complex. 
This is not what we observed. Reactions containing 2 M 
FGE, 2 M Cu(I) and 2 mM of either cysteamine (KD = 10-14.0 
M), DTT (KD = 10-15.1  M) or dithiobutylamine (DTBA, KD = 10-
15.8 M)[13] displayed approximately the same rate of product 
formation (Figure S2), showing that the Cu(I) affinity of the 
redox buffer does not influence catalytic activity.  
One explanation for this behavior could be that the Cu(I) 
affinity of FGE in the presence of substrate is at least two 
orders of magnitude higher than that determined for the 
resting enzyme. We could not directly measure the Cu(I) 
affinity of the enzyme:substrate complex because the 
substrate peptide (sequence: Abz-SALCSPTRA-NH2) is a 
proficient Cu(I) binder in its own right, meaning that saturating 
concentrations of this peptide are incompatible with the 
titration assay. A substrate analog containing a Ser instead of 
the Cys residue  (sequence: Abz-SALSSPTRA-NH2) did not 
interfere with this assay, but also proved a poor FGE ligand 
(Figure S3). Consequently, the presence of this peptide did 
not change the Cu (I) affinity of either FGE4C or FGES266A.  
As an alternative strategy to gauge the influence of the 
substrate on Cu (I) binding by FGE we analyzed the ability of 
FGE4C and inactive FGE variants to exchange Cu (I) during 
catalysis. To conduct this experiment, we designed four 
variants of FGE4C using a structural model based on the 
crystal structure of human FGE (Figure 1). We produced two  
 
 
Figure 1. Structural model of FGEcurvata based on the structure of human 
FGE (PDB code: 2AIJ).[4c, 14] Residues 4 – 8 of the substrate were modeled 
according to a similar substrate bound to the human enzyme. This model 
suggests that Ser290 makes a 3.0Å hydrogen bond to Arg8 on the 
substrate (dashed line). 
variants that each has one of the active site cysteines 
mutated to serine (FGEC269S and FGEC274S). Both proteins 
proved essentially inactive and devoid of measurable Cu(I) 
affinity (Table 1). Apparently both thiols are important for 
Cu(I) binding and also for catalysis. The third variant has a 
conserved active site serine at position 266 mutated to 
alanine (FGES266A). This mutation reduced kcat by 270-fold, but 
did not affect KM, and did not interfere with copper binding (KD 
= 10-17.6 M). The mutation in the fourth variant (FGES290K) was 
designed to impair substrate binding. Ser290 is located at the 
bottom of the substrate binding groove, more than 15 Å away 
from the catalytic site (Figure 1).[4c] We mutated this Ser 
residue to Lys in order to block substrate binding through 
steric and coulombic repulsion. As expected, the 
corresponding protein can not be saturated with substrate 
and the catalytic efficiency (kcat/KM) is reduced by 440-fold. At 
the same time Cu(I) affinity was only reduced by 2.5 fold (KD 
= 10-16.7 M) (Table 1). 
We tested the ability of these variants to compete with FGE4C 
for Cu(I) during catalysis in reactions containing 0.5 M 
FGE4C, 0.5 M CuSO4, 2 mM DTT, 50 mM EDTA and 200 M 
substrate  (Figure 2). One minute after these reactions were 
initiated by addition of FGE4C, we added a 9-fold excess of 
FGEC269S, FGEC274S, FGES266A, FGES290K or BSA (Figure 2). 
Addition of FGES266A reduced FGE4C activity by approximately 
15-fold (m2/m1, Figure 2a), consistent with redistribution of 
limiting Cu(I) among 0.5 M FGE4C and 4.5 M FGES266A. 
Addition of more Cu (I) to this inhibited reaction immediately 
restored full activity to FGE4C (Figure S4), confirming Cu (I) as 
the limiting factor.    
The rate at which Cu (I) redistributed between FGE4C and 
FGES266A (0.07 ± 0.02 min-1, Figure 2) provides an estimation 
of how fast the FGE4C:Cu(I) complex decays (koff,Cu(I)) (Figure 
2). This rate is eleven-fold slower than catalytic turnover 
(m2/[FGE4C] = 0.8 min-1), meaning that metal binding and 
unbinding cannot be part of the catalytic cycle. The same 
competition experiment shows that BSA, FGEC269S, FGEC274S 
or FGES290K cannot extract Cu(I) from FGE4C. For BSA and 
the two cysteine variants this result is consistent with their 
complete lack of Cu(I) affinity (Table 1). FGES290K on the other 
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Figure 2: FGE4C catalyzed product formation as a function of time (○) in reactions containing 0.5 µM FGE4C, 200 µM substrate, 0.5 µM CuSO4, 2 mM DTT, 50 mM 
EDTA, 50 mM NaCl and 50 mM Tris pH8. Identical reactions were supplemented with 5 µM FGES266A (A), FGEC274S (B), FGEC269S (C), BSA (D), FGES290K (E), one 
minute after initiation with FGE4C (▲). In Figure 2a the ▲-data were fitted to the function [P] = A∙(1-exp(-koff,Cu(I)∙t))+m1∙t (solid line), the O-data were fitted to the 
function [P] = m2∙t (dashed line). A corresponds to the concentration of product formed until Cu(I) redistribution between FGE4C and FGES266A is completed (= 4.0 
µM). koff,Cu(I) corresponds to the rate at which the FGE4C:Cu(I) complex decays (= 0.07 min-1). m1 corresponds to the residual activity after Cu(I) redistribution 
(m1/[FGE4C] = 0.05 min-1). m2 corresponds to the activity of Cu(I) complemented FGE4C (m2/[FGE4C] = 0.8 min-1). The presented data corresponds to averaged 
values of two or more independent experiments. 
 
 
Figure 3. X-band (~9.52 GHz) continuous-wave EPR spectra of 50 M 
FGE4C and 0.5 mM substrate in the presence and absence of 50 µM 
CuSO4 and 5 mM DTT. Temperature: 150 K, modulation amplitude: 1 mT, 
microwave attenuation: 15 dB (6.346 mW power), 160 scans each. Spectra 
were acquired on a Bruker Elexsys 500 spectrometer equipped with a 
super-high Q resonator. Left: Detail spectra in the region of the strongest 
Cu(II) signal component. Right: Full spectrum of the Cu(II) species 
observed in the absence of DTT. 
 
hand, is a strong Cu (I) binder (Table 1) but its ternary 
complex with copper and substrate is weak. The observation 
that FGES290K cannot sequester Cu (I) from the FGE4C 
catalyzed reaction is consistent with the idea  that substrate 
binding increases the apparent Cu (I) affinity of the enzyme. 
This finding, in combination with the observation that the Ser 
containing substrate analog is a poor FGE ligand indicate that 
the thiol function of the substrate might be the third copper 
ligand in the active site.  
As a final experiment we used EPR spectroscopy to probe 
the redox state of copper bound to FGE4C. Freeze quenched 
reactions containing FGE4C, Cu(I), EDTA, DTT and substrate 
yielded a featureless EPR spectrum, not significantly different 
from that measured with a control sample without added 
copper (Figure 3). Apparently, the accumulating copper 
species during catalysis is EPR silent. By contrast, a sample 
without DTT showed the clear EPR signal of Cu(II), whereas 
a control reaction containing no DTT and no added copper 
again is EPR silent (Figure 3). Accumulation of a Cu(II) 
species is consistent with the fact that in absence of DTT 
FGE4C oxidizes to the disulfide form and looses any affinity 
for copper. 
The combination of catalytic and structural properties of FGE 
described here and elsewhere [4a-c, 7, 15] strongly implicates  
 
Scheme 2. Plausible catalytic mechanism of FGE catalyzed formylglycine 
formation. 
 
FGE as a copper-metalloenzyme: The active form of FGE 
strongly binds one equivalent of Cu (I) in the active site;[7b] the 
Cu(I):protein complex remains intact throughout the entire 
catalytic cycle (Figure 2); other transition metals cannot 
complement FGE,[7] suggesting that the cofactor engages in 
redox chemistry;[8] FGE reduces O2 using two electrons form 
the substrate and two electrons from an auxiliary reducing 
agent such as DTT;[4a, 7b]  in presence of DTT the rate limiting 
step is hydrogen atom abstraction from the substrate; [7b] the 
accumulating species during catalysis is an EPR silent 
species (Figure 3); in absence of an appropriate reducing 
agent turnover becomes much slower,[4a, 4b, 7] and a Cu(II) 
containing species accumulates (Figure 3); this oxidized 
species can slowly turn over using the substrate thiol as an 
electron source;[7b] and finally, addition of a proper reducing 
agent to this slow reaction immediately reactivates the 
enzyme.[7b, 15] In our view these observations are best 
consolidated in the following mechanistic proposal (Scheme 
2): The cuprous state of FGE (a) binds substrate (b) and O2 
to form a cupric superoxo intermediate (c). Hydrogen atom 
transfer (HAT) and electron transfer (ET) from the substrate 
reduce this intermediate to a Cu (I) hydroperoxo complex (d). 
The resulting thioaldehyde hydrolyzes to form the fGly 
containing product and hydrogen sulfide and the hydroperoxo 
complex collapses into a stable but oxidized form of FGE (e). 
In presence of DTT this species is quickly reduced to the 
active resting state (a). In absence of a proper reducing agent, 
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species e decays to the disulfide form of FGE (f) that does 
not bind copper. Therefore Cu (I) leaves the active site and 
oxidizes to Cu (II). A much slower three-electron process 
restores the reduced FGE:Cu(I) complex (a). 
The absence of any EPR signature during turnover may be 
explained by the following scenarios: a) the cupric superoxo 
species (c, Scheme 2) is not formed or does not accumulate to a 
significant extent, even though the following HAT is rate limiting; 
b) species c does accumulate but has a diamagnetic singlet 
ground state due to a highly covalent interaction between Cu (II) 
and superoxide;[16] or c) the accumulating Cu (II) species has a 
triplet ground state hat does not produce an EPR signature in the 
X-band spectrum.[17] The reactivity of previously characterized Cu 
(II) superoxo complexes showed that diamagnetic species 
generally do not cleave C-H bonds,[16, 18] whereas paramagnetic 
species do.[19] Based on this precedence we predict that FGE 
forms an EPR-silent paramagnetic Cu (II) superoxo species that 
mediates homolytic C-H bond cleavage.  
A similar sequence of events has been implicated in the catalytic 
mechanisms of the copper enzymes polysaccharide 
monooxygenase (PMO)[20] -hydroxylating 
monooxygenase (PHM).[8a, 21] In PHM a Cu (II) superoxo species 
has been shown to cleav -H bond of a C-terminal glycine 
residue. Electron transfer from a neighbouring Cu (I) center forms 
the Cu (I) hydroperoxo species, that immediately eliminates water 
to form Cu (II)-oxyl which in turn hydroxylates the substrate 
radical. In PMOs a Cu (II) superoxo species has been proposed 
to extract a hydrogen atom from the anomeric carbon (C1) in 
polysaccharides. Electron transfer from an auxiliary reducing 
agent forms a Cu (I) hydroperoxo complex, followed by Cu (II)-
oxyl formation, followed by hydroxylation of the substrate radical. 
FGE, PMO and PHM oxidize their substrates by two electrons 
and therefore depend on a reducing agent to fully reduce oxygen. 
PHM activity depends on ascorbate,[8a] in vitro activity of FGE 
depends on thiols, and PMOs seem to accept electron donors 
such as gallic acid or the reduced form of cellobiose 
dehydrogenase.[20a] Future investigations will tell to what detail 
these three reactions follow analogous pathways.  
 
In conclusion, the presented data shows that FGE is a 
copper-dependent oxygenase. Although the reduced 
enzyme:Cu(I) complex is very stable, it is highly sensitive to 
autooxidation. The apparent instability under aerobic 
conditions may explain the previous difficulties to trace Cu (I) 
in the active site of FGE by crystallography. This discovery 
raises novel questions about the in vivo copper delivery to 
FGE, and highlights a potential connection between oxidative 
stress, copper homeostasis and sulfatase deficiencies in 
humans.  
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